Details for New Drug Application (NDA): 202344
✉ Email this page to a colleague
The generic ingredient in BINOSTO is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for 202344
Tradename: | BINOSTO |
Applicant: | Radius |
Ingredient: | alendronate sodium |
Patents: | 1 |
Suppliers and Packaging for NDA: 202344
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344 | NDA | ASCEND Therapeutics | 17139-400 | 17139-400-01 | 1 TABLET, EFFERVESCENT in 1 CARTON (17139-400-01) |
BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344 | NDA | ASCEND Therapeutics | 17139-400 | 17139-400-04 | 4 TABLET, EFFERVESCENT in 1 CARTON (17139-400-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EFFERVESCENT;ORAL | Strength | EQ 70MG BASE | ||||
Approval Date: | Mar 12, 2012 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 5, 2031 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 202344
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Radius | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Radius | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription